Traders Sell Johnson & Johnson (JNJ) on Strength (JNJ)
Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading on Monday. $180.60 million flowed into the stock on the tick-up and $255.41 million flowed out of the stock on the tick-down, for a money net flow of $74.81 million out of the stock. Of all companies tracked, Johnson & Johnson had the 22nd highest net out-flow for the day. Johnson & Johnson traded up $1.92 for the day and closed at $133.15
JNJ has been the topic of several recent research reports. Royal Bank of Canada reiterated a “buy” rating on shares of Johnson & Johnson in a report on Tuesday, January 9th. Credit Suisse Group set a $154.00 target price on shares of Johnson & Johnson and gave the stock a “hold” rating in a report on Monday, January 22nd. Wells Fargo & Co reiterated an “outperform” rating and set a $160.00 target price (up from $155.00) on shares of Johnson & Johnson in a report on Friday, January 12th. Zacks Investment Research cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Tuesday, December 12th. Finally, JPMorgan Chase & Co. cut shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $146.16.
The stock has a market capitalization of $357,710.00, a price-to-earnings ratio of 341.41, a price-to-earnings-growth ratio of 2.23 and a beta of 0.74. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.02 and a current ratio of 1.32.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Stockholders of record on Tuesday, February 27th will be issued a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.52%. The ex-dividend date of this dividend is Monday, February 26th. Johnson & Johnson’s dividend payout ratio is currently 861.54%.
Several large investors have recently added to or reduced their stakes in the company. Goodman Financial Corp purchased a new position in shares of Johnson & Johnson in the 4th quarter valued at approximately $104,000. Harding Loevner LP purchased a new position in shares of Johnson & Johnson in the 2nd quarter valued at approximately $106,000. Stelac Advisory Services LLC purchased a new position in shares of Johnson & Johnson in the 4th quarter valued at approximately $108,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its position in shares of Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after purchasing an additional 200 shares during the last quarter. Finally, IHT Wealth Management LLC raised its position in shares of Johnson & Johnson by 46.4% in the 2nd quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after purchasing an additional 3,467 shares during the last quarter. Institutional investors and hedge funds own 65.58% of the company’s stock.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.